Xoran Announces New Leadership for its ENT Division
We are excited to share that Xoran Technologies has created a new customer-focused leadership team to drive growth and innovation in its ENT and Veterinary divisions. This strategic reorganization enables Xoran to better focus on meeting the evolving needs of its customers.
Xoran’s ENT division is now comprised of a team of experts committed to helping our customers tackle their most important goals. William van Kampen, MBA, has been promoted to General Manager. Will has 18 years of medical device development and commercialization experience and most recently served as Xoran’s Chief Technology Officer. With over 15 years of industry experience serving ENT customers, Rami Al-Zoubi continues in his role as National Sales Director. Rounding out the ENT division are Russell Jahnke, ENT Market Manager, and Jim Bertolina, PhD, Director of Business Development. Together, Russell and Jim bring more than 30 years of medical device expertise to our ENT division.
“This is a pivotal moment for Xoran to strengthen our responsiveness to customers and partners within this key market segment. Our team is now laser-focused on providing solutions that improve workflow and the overall healthcare experience for physicians and patients. I am excited for the opportunity for this new team to work closely with doctors and practice managers to better understand and provide solutions for the unique and evolving needs of their practices.”
— William van Kampen, ENT General Manager, Xoran Technologies
Additional changes to Xoran’s executive leadership team includes the promotion of Dr. David Sarment to General Manager of Xoran’s Veterinary division, the promotion of Dejan Teofilovic as Chief Technology Officer, and the promotion of Mark McGarrow as Chief Operating Officer.
We appreciate and value your partnership. As Xoran has evolved over the years, we have remained keenly focused on the success of our customers. You are at the forefront of healthcare innovation, solving some of the most complex challenges to improve patient care. We remain committed to you and we look forward to working together to bring fresh perspectives to ensure we meet the evolving needs of patients.
